Literature DB >> 31053682

Imaging of CAR T-Cells in Cancer Patients: Paving the Way to Treatment Monitoring and Outcome Prediction.

Simone Krebs1, Vladimir Ponomarev2, Susan Slovin3, Heiko Schöder4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31053682     DOI： 10.2967/jnumed.119.227561

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  6 in total

Review 1.  Probing immune infiltration dynamics in cancer by in vivo imaging.

Authors:  Thomas S C Ng; Harris H Allen; Mohammad Rashidian; Miles A Miller
Journal:  Curr Opin Chem Biol       Date:  2022-02-23       Impact factor: 8.972

Review 2.  Interfacing Biomaterials with Synthetic T Cell Immunity.

Authors:  Fang-Yi Su; Quoc D Mac; Anirudh Sivakumar; Gabriel A Kwong
Journal:  Adv Healthc Mater       Date:  2021-04-22       Impact factor: 11.092

3.  Early toxicity and clinical outcomes after chimeric antigen receptor T-cell (CAR-T) therapy for lymphoma.

Authors:  Jonathan E Brammer; Zachary Braunstein; Aashish Katapadi; Kyle Porter; Michael Biersmith; Avirup Guha; Sumithira Vasu; Vedat O Yildiz; Sakima A Smith; Benjamin Buck; Devin Haddad; Richard Gumina; Basem M William; Sam Penza; Ayman Saad; Nathan Denlinger; Ajay Vallakati; Ragavendra Baliga; Raymond Benza; Philip Binkley; Lai Wei; Mason Mocarski; Steven M Devine; Samantha Jaglowski; Daniel Addison
Journal:  J Immunother Cancer       Date:  2021-08       Impact factor: 12.469

4.  Metabolic radiolabeling and in vivo PET imaging of cytotoxic T lymphocytes to guide combination adoptive cell transfer cancer therapy.

Authors:  Dehua Lu; Yanpu Wang; Ting Zhang; Feng Wang; Kui Li; Shixin Zhou; Hua Zhu; Zhi Yang; Zhaofei Liu
Journal:  J Nanobiotechnology       Date:  2021-06-10       Impact factor: 10.435

Review 5.  Current and Future Role of Medical Imaging in Guiding the Management of Patients With Relapsed and Refractory Non-Hodgkin Lymphoma Treated With CAR T-Cell Therapy.

Authors:  Laetitia Vercellino; Dorine de Jong; Roberta di Blasi; Salim Kanoun; Ran Reshef; Lawrence H Schwartz; Laurent Dercle
Journal:  Front Oncol       Date:  2021-05-28       Impact factor: 6.244

6.  Pharmacokinetic and pharmacodynamic studies of CD19 CAR T cell in human leukaemic xenograft models with dual-modality imaging.

Authors:  Qiong Wu; Yan Wang; Xinyu Wang; Ningxia Liang; Jingjing Liu; Donghui Pan; Yuping Xu; Lizhen Wang; Junjie Yan; Guangji Wang; Liyan Miao; Min Yang
Journal:  J Cell Mol Med       Date:  2021-07-09       Impact factor: 5.310
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.